Transcat (NASDAQ:TRNS) Price Target Raised to $110.00 at Northland Securities

Transcat (NASDAQ:TRNS – Get Rating) had its target price increased by Northland Securities from $100.00 to $110.00 in a research note published on Wednesday morning, The Fly reports.

A number of other equities research analysts have also recently commented on TRNS. HC Wainwright raised their target price on shares of Transcat from $96.00 to $102.00 in a research note on Wednesday. Craig Hallum raised their target price on shares of Transcat from $81.00 to $92.00 and gave the stock a buy rating in a research note on Wednesday, February 1st. Roth Capital raised their target price on shares of Transcat from $80.00 to $94.00 and gave the stock a buy rating in a research note on Thursday, February 2nd. Finally, StockNews.com started coverage on shares of Transcat in a research note on Thursday, May 18th. They set a hold rating on the stock. One analyst has rated the stock with a hold rating and four have issued a buy rating to the stock. According to MarketBeat.com, the stock has an average rating of Moderate Buy and a consensus price target of $102.25.

Transcat Price Performance

Shares of NASDAQ:TRNS opened at $89.67 on Wednesday. The firm’s 50 day moving average price is $83.92 and its 200-day moving average price is $81.90. Transcat has a twelve month low of $50.32 and a twelve month high of $94.10. The company has a quick ratio of 1.75, a current ratio of 2.42 and a debt-to-equity ratio of 0.49. The stock has a market capitalization of $685.08 million, a PE ratio of 64.05 and a beta of 0.76.

Institutional Investors Weigh In On Transcat

Several institutional investors and hedge funds have recently modified their holdings of the stock. Neuberger Berman Group LLC raised its position in shares of Transcat by 0.4% during the fourth quarter. Neuberger Berman Group LLC now owns 842,398 shares of the scientific and technical instruments company’s stock valued at $59,701,000 after buying an additional 3,506 shares during the last quarter. Conestoga Capital Advisors LLC raised its position in shares of Transcat by 0.6% during the first quarter. Conestoga Capital Advisors LLC now owns 731,044 shares of the scientific and technical instruments company’s stock valued at $65,348,000 after buying an additional 4,217 shares during the last quarter. Fred Alger Management LLC raised its position in shares of Transcat by 6.1% during the first quarter. Fred Alger Management LLC now owns 727,225 shares of the scientific and technical instruments company’s stock valued at $65,007,000 after buying an additional 41,563 shares during the last quarter. Broadcrest Asset Management LLC raised its position in shares of Transcat by 8.9% during the fourth quarter. Broadcrest Asset Management LLC now owns 490,000 shares of the scientific and technical instruments company’s stock valued at $34,726,000 after buying an additional 40,000 shares during the last quarter. Finally, BlackRock Inc. raised its position in shares of Transcat by 0.5% during the first quarter. BlackRock Inc. now owns 457,722 shares of the scientific and technical instruments company’s stock valued at $40,916,000 after buying an additional 2,270 shares during the last quarter. Institutional investors own 83.24% of the company’s stock.

About Transcat

(Get Rating)

Transcat, Inc engages in provision of calibration and laboratory instrument services. It operates through the Service and Distribution segments. The Service segment offers calibration, repair, inspection, analytical qualifications, preventive maintenance, consulting, and other related services. The Distribution segment distributes professional grade test, measurement, and control instrumentation.